OXEPA

Country: Իսրայել

language: անգլերեն

source: Ministry of Health

active_ingredient:

ACID CASEIN 5.9 G / 100 ML; ARTIFICIAL VANILLA 116 MG / 100 ML

MAH:

ABBOTT MEDICAL LABORATORIES LTD

ATC_code:

B05XA30

pharmaceutical_form:

LIQUID

administration_route:

TUBE FEEDING

manufactured_by:

ABBOTT NUTRITION - ABBOTT LABORATORIES, USA

therapeutic_group:

COMBINATIONS OF ELECTROLYTES

therapeutic_indication:

Oxepa is clinically shown to modulate the inflammatory response in critically ill, mechanically ventilated patients. It is appropriate for patients who have sepsis, ALI (acute lung injury), or ARDS (acute respiratory distress syndrome).

authorization_date:

2012-01-01